A Conversation With Matt McCall it up. You know, Kobe Bryant’s new sports drink just got bought up for a ton of money. You know, any time a little guy comes up, they get bought up.
Porter Stansberry: Very interesting. Beyond marijuana, I wanted to ask you for your next best growth sector. What’s another huge growth sector that you’re focused on? MATT McCALL: I’m going to say health care, and within there more particularly, gene editing... There are three publicly traded companies that really use what’s called CRISPR-Cas9 – it’s a way to edit genes in the future. That, to me, is going to be a game changer, along with genetic-testing companies. There are a lot of companies that are small right now, but they are kind of the “picks and shovels” of the health care industry, and they will be needed for anything going forward... And what’s going to happen is, instead of looking at family history, look at my genes, what I’m made up of. Look at my genomes,
So, you will see this. I mean, in my marijuana watch list I have here in my trading system, I have more than 200 stocks. One hundred of them will not be around, I will guarantee that, maybe 150 will not be around in three or four years. You know, they’re little. They’re jokes, they’re little players. A lot of them will be bought up by the big names. But a company like Canopy, which Constellation owns 38% of, it’s been buying up smaller companies and it will continue. And the key that’s often overlooked in marijuana is, you talked about Canada, which you can buy recreationally for the first time, and you look at the U.S. – this is a global play. When I was in Italy last week, in Rome, they had these new cannabis shops that went up earlier this year. They’re very low-grade cannabis, so you can walk right in and buy it. So, if you see the EU legalizes marijuana – which it will, in my opinion, in the next four or five years – that’s a huge boom. Australia is supposed to be a huge market for it. So, there’s going to be a lot of international plays, and the only way for companies to take advantage of that is to be a big-name player, like you said. I don’t think Philip Morris is getting into it. I think that company’s in trouble. But I think you’re going to see some of the soft drink and some of the food companies really make big moves into the space.
For the full Investor Hour show with Buck Sexton, Porter Stansberry, and Matt McCall, click here to sign up for the Investor Hour notification list. Like American Consequences , it's 100% free. Each week, you'll receive new show updates, previews, and access to transcripts and show notes. Whether it's about investing... business... politics... or a controversial social issue... you'll get the unfiltered information from behind the scenes.
76 October 2018
Made with FlippingBook Online newsletter